What Has Everyone Excited about COVID-19 Vaccines for 5-11-year-olds?
With the rollout this month of the COVID-19 vaccine for those 5-11 years of age, we can now directly protect children with asthma for whom COVID-19 infection is an even bigger hazard for our children during the pandemic.
During the COVID-19 pandemic, the term “comorbidities” has entered our daily vernacular, mostly in reference to adults’ chronic illnesses such as cancer, heart disease and diabetes, but with pediatric
Read More
Coronavirus (COVID-19)
How IVAs are Helping Care Providers and Patients Deal with Delta Variant
Communicating clearly and effectively with patients is a hallmark of good patient care. However, as the Delta Variant defines the next phase of COVID, many healthcare organizations are experiencing a massive surge in patient communication volume. Not only do they need to communicate important updates about the virus, testing, appointments, and vaccinations; but they are also still dealing with a swell of inbound questions from patients needing answers to ongoing healthcare concerns they may have
Read More
Respira Launches AI Wearable for Lung Function for COPD, COVID, Asthma
What You Should Know:
- Today, Respira is introducing its AI wearable technology to monitor for certain very serious lung conditions. According to the Institute for Health Metrics and Evaluation, COPD (Chronic Obstructive Pulmonary Disease) and COVID-19 were the 3rd and 4th global causes of death during the height of the pandemic. Asthma, according to the World Health Organization, is the most common chronic disease among children.
- Chest wearable uses tiny speakers and microphones to
Read More
Time is Money in Healthcare Administration. How Much Are You Losing?
Administrative complexity is a billion-dollar problem, riddled with human-led, hand-done steps that simply don’t need to exist.
In a given year, approximately a quarter to one-third of our healthcare spending comes from waste across the system. Sometimes, the cause of money waste is obvious, such as duplicated tests, misdiagnosis, extended ER stays, overtreatment, or failures in care coordination. The less obvious contributor: time.
Time is wasted at nearly every step of the
Read More
Decentralized Clinical Research Will Be A Paradigm-Shifting Trend
The field of clinical research is on the precipice of change, and for good reason. Traditional clinical trials and processes are primarily confined to sterile, isolated clinical settings that are often narrow in scope and provider-centric. Researchers of tomorrow, however, already are identifying accurate and effective new methods to conduct and draw meaning from their work, after concluding that current models for clinical research are not capturing participants’ real-world, lived experiences
Read More
Cue Health Launches DTC Virtual Health Platform Featuring COVID-19 Self Test
What You Should Know:
- Cue Health (Nasdaq: HLTH), a healthcare technology company, launches its direct-to-consumer (DTC) virtual health platform, making its first-of-its-kind molecular COVID-19 test available to people across the United States. Cue helps keep NBA players safe both on and off the court, supports the well-being of Google’s employees wherever they are, and keeps front-line workers well informed at the Mayo Clinic.
- Beyond COVID-19 testing needs, Cue’s virtual platform
Read More
Color Raises $100M at $4.6B Valuation to Expand Accessible, Equitable Public Health Infrastructure
What You Should Know:
- Color, a San Francisco, CA-based health technology company committed to advancing public health, announced a $100 million Series E financing round at a valuation of $4.6 billion led by Kindred Ventures and by certain funds and accounts advised by T. Rowe Price Associates, Inc. with participation by existing investors General Catalyst, Viking Global Investors, and Emerson Collective.
- Color makes population-scale healthcare programs accessible, convenient, and
Read More
FDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 Treatments
What You Should Know:
- Aetion, a NYC-based leading real-world evidence (RWE) company, announced that the U.S. Food and Drug Administration (FDA) has contracted with them to use their Aetion Evidence Platform® to rapidly assess in-patient COVID-19 treatments and advance regulatory science to help determine when, where and how to use RWD.
- This project is designed to demonstrate how using a platform-based approach
Read More
10 Tips for Improving COVID-19 Employee Immunization Initiatives
Within the past 18 months, what used to be a relatively simple process for organizations providing healthcare services – ensuring their employees had required and recommended vaccines – has gotten contentious and complicated – to say the least.
The rise of the COVID-19 Delta variant and new immunization mandates creates concerns and complexities for hospitals, nursing homes, long-term care and other providers. As of early October, the CDC has approved Pfizer booster
Read More
Lessons Learned: The Impact of COVID-19 on Infusion Center Scheduling
Over the past year, COVID-19 brought new stresses to hospital scheduling, given limited resources, physician availability, staffing challenges and physical materials. Beyond the obvious struggles with ICU capacity, COVID-19 also put a heavy strain on every step of the chemotherapy patient journey – from navigating new scheduling protocols to pre-screening to delays in diagnosis to reconfigured, socially distanced waiting rooms and treatment chairs. As we continue to navigate the pandemic, many
Read More
